Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis.
Kasi A, Abbasi S, Handa S, Al-Rajabi R, Saeed A, Baranda J, Sun W.
JAMA Netw Open. 2020 Dec 1;3(12):e2030097. doi: 10.1001/jamanetworkopen.2020.30097.
Multicenter phase II trial of transanal total mesorectal excision for rectal cancer: preliminary results.
Sylla P, Sands D, Ricardo A, Bonaccorso A, Polydorides A, Berho M, Marks J, Maykel J, Alavi K, Zaghiyan K, Whiteford M, Mclemore E, Chadi S, Shawki SF, Steele S, Pigazzi A, Albert M, DeBeche-Adams T, Moshier E, Wexner SD.
Surg Endosc. 2023 Dec;37(12):9483-9508. doi: 10.1007/s00464-023-10266-9. Epub 2023 Sep 12.
Long-Term Outcomes of the Excluded Rectum in Crohn's Disease: A Multicenter International Study.
Kassim G, Yzet C, Nair N, Debebe A, Rendon A, Colombel JF, Traboulsi C, Rubin DT, Maroli A, Coppola E, Carvello MM, Ben David N, De Lucia F, Sacchi M, Danese S, Spinelli A, Hirdes MMC, Ten Hove J, Oldenburg B, Cholapranee A, Riter M, Lukin D, Scherl E, Eren E, Sultan KS, Axelrad J, Sachar DB.
Inflamm Bowel Dis. 2023 Mar 1;29(3):417-422. doi: 10.1093/ibd/izac099.
Persistent involvement of anterior mesorectal fascia in carcinoma rectum - extended resection of rectum vs total pelvic exenteration: results from a single-centre retrospective study.
Verma K, Engineer R, Ostwal V, Kumar S, Arya S, Desouza AL, Saklani AP.
Colorectal Dis. 2018 Dec;20(12):1070-1077. doi: 10.1111/codi.14336. Epub 2018 Aug 14.
Trajectory of change of low anterior resection syndrome over time after restorative proctectomy for rectal adenocarcinoma.
Al-Rashid F, Robitaille S, Liberman AS, Charlebois P, Stein B, Feldman LS, Fiore JF Jr, Lee L.
Tech Coloproctol. 2022 Mar;26(3):195-203. doi: 10.1007/s10151-021-02561-1. Epub 2022 Jan 18.
Improvement of low anterior resection syndrome beyond 2 years after total mesorectal excision.
He S, Liu Z, Li L, Zhang J, Shi L, Song Y, Lin H, Sun W, Wang J, Deng Y, Wang H, Kang L, Dou R.
J Surg Oncol. 2022 Mar;125(3):448-456. doi: 10.1002/jso.26729. Epub 2021 Oct 24.
The role of transanal total mesorectal excision.
Rutgers MLW, Bemelman WA, Khan JS, Hompes R.
Surg Oncol. 2022 Aug;43:101695. doi: 10.1016/j.suronc.2021.101695. Epub 2021 Dec 12.
Research highlight: surgical outcomes of gluteal VY plasty after extensive abdominoperineal resection or total pelvic exenteration.
Gielen AHC, Colier E, Qiu SS, Keymeulen KBMI, Stassen LPS, Melenhorst J.
Langenbecks Arch Surg. 2023 Apr 24;408(1):157. doi: 10.1007/s00423-023-02896-3.
Oncologic outcomes of intersphincteric resection versus abdominoperineal resection for lower rectal cancer: a systematic review and meta-analysis.
Du Q, Yang W, Zhang J, Qiu S, Liu X, Wang Y, Yang L, Zhou Z.
Int J Surg. 2024 Apr 1;110(4):2338-2348. doi: 10.1097/JS9.0000000000000205.
Outcomes of transanal total mesorectal excision compared to laparoscopic total mesorectal excision: A meta-analysis of randomized controlled trials.
Emile SH, Wignakumar A, Horesh N, Garoufalia Z, Rogers P, Zhou P, Strassmann V, Wexner SD.
Surgery. 2024 Feb;175(2):289-296. doi: 10.1016/j.surg.2023.10.006. Epub 2023 Nov 23.
